BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28766880)

  • 1. MMP-2 and MMP-13 affect vasculogenic mimicry formation in large cell lung cancer.
    Li Y; Sun B; Zhao X; Wang X; Zhang D; Gu Q; Liu T
    J Cell Mol Med; 2017 Dec; 21(12):3741-3751. PubMed ID: 28766880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subpopulations of uPAR+ contribute to vasculogenic mimicry and metastasis in large cell lung cancer.
    Li Y; Sun B; Zhao X; Zhang D; Wang X; Zhu D; Yang Z; Qiu Z; Ban X
    Exp Mol Pathol; 2015 Apr; 98(2):136-44. PubMed ID: 25661888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway.
    Zhang JT; Sun W; Zhang WZ; Ge CY; Liu ZY; Zhao ZM; Lu XS; Fan YZ
    BMC Cancer; 2014 Mar; 14():193. PubMed ID: 24628713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual effects of collagenase-3 on melanoma: metastasis promotion and disruption of vasculogenic mimicry.
    Zhao X; Sun B; Li Y; Liu Y; Zhang D; Wang X; Gu Q; Zhao J; Dong X; Liu Z; Che N
    Oncotarget; 2015 Apr; 6(11):8890-9. PubMed ID: 25749207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Non-Coding RNA HOXA-AS2 Regulates Malignant Glioma Behaviors and Vasculogenic Mimicry Formation via the MiR-373/EGFR Axis.
    Gao Y; Yu H; Liu Y; Liu X; Zheng J; Ma J; Gong W; Chen J; Zhao L; Tian Y; Xue Y
    Cell Physiol Biochem; 2018; 45(1):131-147. PubMed ID: 29310118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rictor regulates the vasculogenic mimicry of melanoma via the AKT-MMP-2/9 pathway.
    Liang X; Sun R; Zhao X; Zhang Y; Gu Q; Dong X; Zhang D; Sun J; Sun B
    J Cell Mol Med; 2017 Dec; 21(12):3579-3591. PubMed ID: 28699701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of the PI3K/MMPs/Ln-5γ2 and EphA2/FAK/Paxillin signaling pathways to tumor growth and vasculogenic mimicry of gallbladder carcinomas.
    Lu XS; Sun W; Ge CY; Zhang WZ; Fan YZ
    Int J Oncol; 2013 Jun; 42(6):2103-15. PubMed ID: 23588386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma.
    Seftor RE; Seftor EA; Koshikawa N; Meltzer PS; Gardner LM; Bilban M; Stetler-Stevenson WG; Quaranta V; Hendrix MJ
    Cancer Res; 2001 Sep; 61(17):6322-7. PubMed ID: 11522618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of compound DMBT on hypoxia-induced vasculogenic mimicry in human breast cancer.
    Li S; Zhang Q; Zhou L; Guan Y; Chen S; Zhang Y; Han X
    Biomed Pharmacother; 2017 Dec; 96():982-992. PubMed ID: 29208325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP-2 and inducing mesenchymal-to-epithelial transition.
    Zhang W; Zhou P; Meng A; Zhang R; Zhou Y
    J Cell Mol Med; 2018 Mar; 22(3):1743-1754. PubMed ID: 29164766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo apatinib inhibits vasculogenic mimicry in melanoma MUM-2B cells.
    Liu ZJ; Zhou YJ; Ding RL; Xie F; Fu SZ; Wu JB; Yang LL; Wen QL
    PLoS One; 2018; 13(7):e0200845. PubMed ID: 30052652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the tumor microenvironment with chemically modified tetracyclines: inhibition of laminin 5 gamma2 chain promigratory fragments and vasculogenic mimicry.
    Seftor RE; Seftor EA; Kirschmann DA; Hendrix MJ
    Mol Cancer Ther; 2002 Nov; 1(13):1173-9. PubMed ID: 12479698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch4 inhibition suppresses invasion and vasculogenic mimicry formation of hepatocellular carcinoma cells.
    Cheng R; Cai XR; Ke K; Chen YL
    J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):719-725. PubMed ID: 29058285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginsenoside Rg3 inhibition of vasculogenic mimicry in pancreatic cancer through downregulation of VE‑cadherin/EphA2/MMP9/MMP2 expression.
    Guo JQ; Zheng QH; Chen H; Chen L; Xu JB; Chen MY; Lu D; Wang ZH; Tong HF; Lin S
    Int J Oncol; 2014 Sep; 45(3):1065-72. PubMed ID: 24938458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dickkopf-1-promoted vasculogenic mimicry in non-small cell lung cancer is associated with EMT and development of a cancer stem-like cell phenotype.
    Yao L; Zhang D; Zhao X; Sun B; Liu Y; Gu Q; Zhang Y; Zhao X; Che N; Zheng Y; Liu F; Wang Y; Meng J
    J Cell Mol Med; 2016 Sep; 20(9):1673-85. PubMed ID: 27240974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-expressed B7-H3 promotes vasculogenic mimicry formation rather than angiogenesis in non-small cell lung cancer.
    Fan X; Huang J; Hu B; Zhou J; Chen L
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8729-8741. PubMed ID: 37129607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CEACAM6 promotes tumor angiogenesis and vasculogenic mimicry in gastric cancer via FAK signaling.
    Zang M; Zhang Y; Zhang B; Hu L; Li J; Fan Z; Wang H; Su L; Zhu Z; Li C; Yan C; Gu Q; Liu B; Yan M
    Biochim Biophys Acta; 2015 May; 1852(5):1020-8. PubMed ID: 25703140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGFBP2 promotes vasculogenic mimicry formation via regulating CD144 and MMP2 expression in glioma.
    Liu Y; Li F; Yang YT; Xu XD; Chen JS; Chen TL; Chen HJ; Zhu YB; Lin JY; Li Y; Xie XM; Sun XL; Ke YQ
    Oncogene; 2019 Mar; 38(11):1815-1831. PubMed ID: 30368528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway.
    Pan MS; Wang H; Ansari KH; Li XP; Sun W; Fan YZ
    J Exp Clin Cancer Res; 2020 Nov; 39(1):234. PubMed ID: 33153467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combretastatin A4 phosphate treatment induces vasculogenic mimicry formation of W256 breast carcinoma tumor in vitro and in vivo.
    Yao N; Ren K; Jiang C; Gao M; Huang D; Lu X; Lou B; Peng F; Yang A; Wang X; Ni Y; Zhang J
    Tumour Biol; 2015 Nov; 36(11):8499-510. PubMed ID: 26026583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.